2LEP

Solution Structure of N-terminal Cytosolic Domain of Rhomboid Intramembrane Protease from Escherichia Coli

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.0 mM [U-100% 13C; U-100% 15N] Nglpg, 25mM NaH2PO4, 150mM NaCl	90% H2O/10% D2O	0.30 M NaCl	6.5	ambient	298.15
2	3D HNCO	1.0 mM [U-100% 13C; U-100% 15N] Nglpg, 25mM NaH2PO4, 150mM NaCl	90% H2O/10% D2O	0.30 M NaCl	6.5	ambient	298.15
3	3D HNCA	1.0 mM [U-100% 13C; U-100% 15N] Nglpg, 25mM NaH2PO4, 150mM NaCl	90% H2O/10% D2O	0.30 M NaCl	6.5	ambient	298.15
4	3D HNCACB	1.0 mM [U-100% 13C; U-100% 15N] Nglpg, 25mM NaH2PO4, 150mM NaCl	90% H2O/10% D2O	0.30 M NaCl	6.5	ambient	298.15
5	3D HBHA(CO)NH	1.0 mM [U-100% 13C; U-100% 15N] Nglpg, 25mM NaH2PO4, 150mM NaCl	90% H2O/10% D2O	0.30 M NaCl	6.5	ambient	298.15
6	3D HN(CO)CA	1.0 mM [U-100% 13C; U-100% 15N] Nglpg, 25mM NaH2PO4, 150mM NaCl	90% H2O/10% D2O	0.30 M NaCl	6.5	ambient	298.15
7	3D HCCH-TOCSY	1.0 mM [U-100% 13C; U-100% 15N] Nglpg, 25mM NaH2PO4, 150mM NaCl	90% H2O/10% D2O	0.30 M NaCl	6.5	ambient	298.15
8	3D 1H-15N NOESY	1.0 mM [U-100% 13C; U-100% 15N] Nglpg, 25mM NaH2PO4, 150mM NaCl	90% H2O/10% D2O	0.30 M NaCl	6.5	ambient	298.15
9	3D 1H-13C NOESY aliphatic	1.0 mM [U-100% 13C; U-100% 15N] Nglpg, 25mM NaH2PO4, 150mM NaCl	100% D2O	0.30 M NaCl	6.5	ambient	298.15
10	3D 1H-13C NOESY aromatic	1.0 mM [U-100% 13C; U-100% 15N] Nglpg, 25mM NaH2PO4, 150mM NaCl	100% D2O	0.30 M NaCl	6.5	ambient	298.15

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	500

NMR Refinement
Method	Details	Software
molecular dynamics	Explicit solvent refinement.	CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
2	refinement	X-PLOR NIH	2.22	Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.